Ann: Appendix 4C - Quarterly - 31 December 2022, page-3

As we all have our own interpretation on things , I'm in agreeance with you Raffout , will be interesting how the Market digests it ?


Also reflecting an active business development program Patrys has commenced work on a series of
experiments directed at conjugating a range of different gene-editing constructs to PAT-DX3. These
experiments are being conducted in collaboration with a potential licensee of the PAT-DX3 technology
and are expected to identify the preferred conjugation methods for attaching nucleic acid payloads to
PAT-DX3. These experiments will potentially create new intellectual property to strengthen Patrys’
business development offering in this commercially-active field.

Hi Mattyedw ,

This Announcement certainly gives credence to what you have been saying along the journey , it's sure and steady progress !

They can shake the tree , supress the price , I ain't letting go of my small parcel .